NSE:JBCHEPHARM Statistics

Total Valuation

NSE:JBCHEPHARM has a market cap or net worth of INR 250.72 billion. The enterprise value is 246.53 billion.

Market Cap	250.72B
Enterprise Value	246.53B

Important Dates

The next estimated earnings date is Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	Feb 7, 2025

Share Statistics

Current Share Class	155.68M
Shares Outstanding	n/a
Shares Change (YoY)	+0.99%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	80.39M

Valuation Ratios

The trailing PE ratio is 38.01 and the forward PE ratio is 30.50.

PE Ratio	38.01
Forward PE	30.50
PS Ratio	6.34
PB Ratio	7.30
P/TBV Ratio	12.18
P/FCF Ratio	31.15
P/OCF Ratio	27.78
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.04, with an EV/FCF ratio of 30.63.

EV / Earnings	37.38
EV / Sales	6.23
EV / EBITDA	23.04
EV / EBIT	27.42
EV / FCF	30.63

Financial Position

The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.01.

Current Ratio	3.04
Quick Ratio	2.00
Debt / Equity	0.01
Debt / EBITDA	0.03
Debt / FCF	0.03
Interest Coverage	76.65

Financial Efficiency

Return on equity (ROE) is 20.75% and return on invested capital (ROIC) is 16.62%.

Return on Equity (ROE)	20.75%
Return on Assets (ROA)	13.59%
Return on Invested Capital (ROIC)	16.62%
Return on Capital Employed (ROCE)	24.69%
Revenue Per Employee	7.45M
Profits Per Employee	1.24M
Employee Count	5,311
Asset Turnover	0.96
Inventory Turnover	2.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.81% in the last 52 weeks. The beta is -0.09, so NSE:JBCHEPHARM's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	-8.81%
50-Day Moving Average	1,591.00
200-Day Moving Average	1,769.67
Relative Strength Index (RSI)	57.33
Average Volume (20 Days)	144,073

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:JBCHEPHARM had revenue of INR 39.56 billion and earned 6.60 billion in profits. Earnings per share was 41.56.

Revenue	39.56B
Gross Profit	26.40B
Operating Income	8.99B
Pretax Income	8.87B
Net Income	6.60B
EBITDA	10.70B
EBIT	8.99B
Earnings Per Share (EPS)	41.56

Full Income Statement

Balance Sheet

The company has 4.47 billion in cash and 278.90 million in debt, giving a net cash position of 4.19 billion.

Cash & Cash Equivalents	4.47B
Total Debt	278.90M
Net Cash	4.19B
Net Cash Per Share	n/a
Equity (Book Value)	34.33B
Book Value Per Share	220.58
Working Capital	12.90B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.02 billion and capital expenditures -975.90 million, giving a free cash flow of 8.05 billion.

Operating Cash Flow	9.02B
Capital Expenditures	-975.90M
Free Cash Flow	8.05B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 66.72%, with operating and profit margins of 22.73% and 16.67%.

Gross Margin	66.72%
Operating Margin	22.73%
Pretax Margin	22.43%
Profit Margin	16.67%
EBITDA Margin	27.05%
EBIT Margin	22.73%
FCF Margin	20.34%

Dividends & Yields

This stock pays an annual dividend of 15.25, which amounts to a dividend yield of 0.93%.

Dividend Per Share	15.25
Dividend Yield	0.93%
Dividend Growth (YoY)	50.62%
Years of Dividend Growth	2
Payout Ratio	35.94%
Buyback Yield	-0.99%
Shareholder Yield	-0.01%
Earnings Yield	2.63%
FCF Yield	3.21%

Dividend Details

Stock Splits

The last stock split was on September 18, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 18, 2023
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a